Transfemoral Replacement of Aortic Valve With HLT MeriDIAN Valve Early Feasibility Trial
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Dean Kereiakes, MD
The Christ Hospital
Principal Investigator - Mathew Williams, MD
NYU Langone Medical Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Medstar Health
Washington D.C., District of Columbia, United States
- St. Vincent Heart Center of Indiana
Indianapolis, Indiana, United States
- Nyu Langone Medical Center
New York, New York, United States
- the Lindner Center for Research and Education at the Christ Hospital
Cincinnati, Ohio, United States
- Baylor Scott & White the Heart Hospital Plano
Plano, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 27 Apr 2017
- Primary completion
- 20 Jan 2023
- Completion
- 20 Jan 2023
- Last update posted
- 31 May 2023
- Registered enrollment
- 11
- Registry id
- NCT02799823
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.